Frazer Lauren C, Orgel Kelly A, Good Misty
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of North Carolina at Chapel Hill, 101 Manning Drive Campus Box 7596, Chapel Hill, NC 27517, USA.
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of North Carolina at Chapel Hill, 101 Manning Drive Campus Box 7596, Chapel Hill, NC 27517, USA.
Gastroenterol Clin North Am. 2025 Jun;54(2):415-427. doi: 10.1016/j.gtc.2024.11.001. Epub 2025 Jan 24.
Necrotizing enterocolitis (NEC) is an inflammatory intestinal disease occurring primarily in infants born prematurely. The etiology is multifactorial and the clinical presentation is nonspecific. Due to the heterogeneity of disease and complexity of the physiology of preterm infants, decades of research have not yielded high-quality diagnostic or treatment strategies. This has translated into a failure to improve outcomes. Prevailing dogma supports a role for intestinal microbial dysbiosis in NEC pathogenesis, and as such, broad-spectrum antibiotics are central to treatment. The specific role of intestinal microbes and how modulation of the microbiome can influence disease remain an area of intensive research.
坏死性小肠结肠炎(NEC)是一种主要发生在早产儿中的炎症性肠道疾病。其病因是多因素的,临床表现不具有特异性。由于疾病的异质性和早产儿生理学的复杂性,数十年的研究尚未产生高质量的诊断或治疗策略。这导致未能改善治疗结果。普遍的观点支持肠道微生物群失调在NEC发病机制中起作用,因此,广谱抗生素是治疗的核心。肠道微生物的具体作用以及微生物群的调节如何影响疾病仍然是一个深入研究的领域。